CT SB00138 | 2020 | General Assembly
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on February 19 2020 - 25% progression, died in chamber
Action: 2020-03-11 - Filed with Legislative Commissioners' Office
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 19 2020 - 25% progression, died in chamber
Action: 2020-03-11 - Filed with Legislative Commissioners' Office
Text: Latest bill text (Introduced) [PDF]
Summary
To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Title
An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.
Sponsors
Roll Calls
2020-03-10 - Joint - GL Vote Tally Sheet (Joint Favorable) (Y: 12 N: 6 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2020-03-11 | Senate | Filed with Legislative Commissioners' Office |
| 2020-03-10 | Senate | Joint Favorable |
| 2020-02-21 | Senate | Public Hearing 02/27 |
| 2020-02-19 | Senate | Referred to Joint Committee on General Law |
